Genome-Wide Methylated DNA Immunoprecipitation Analysis of Patients with Polycystic Ovary Syndrome

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Shen, Hao ran ^a   Qiu, Li hua ^a   Zhang, Zhi qing ^b   Qin, Yuan yuan ^a   Cao, Cong ^b   Di, Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOME WIDE METHYLATED DNA IMMUNOPRECIPITATION; HUMAN; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PROTEIN PROTEIN INTERACTION;

ADULT; CASE-CONTROL STUDIES; DNA METHYLATION; ELECTROPHORESIS, AGAR GEL; ESTROGEN RECEPTOR BETA; FEMALE; GENE ONTOLOGY; GENE REGULATORY NETWORKS; GENOME, HUMAN; HUMANS; IMMUNOPRECIPITATION; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION MAPS; YOUNG ADULT;

EID: 84877963383     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064801     Document Type: Article

References (41)

1. Fauser B, Diedrich K, Bouchard P, Domínguez F, Matzuk M, et al. (2011) Contemporary genetic technologies and female reproduction. Human reproduction update 17: 829-847.
2. Legro RS, Strauss JF, (2002) Molecular progress in infertility: polycystic ovary syndrome. Fertility and sterility 78: 569-576.
3. Diamanti-Kandarakis E, Kandarakis H, Legro RS, (2006) The role of genes and environment in the etiology of PCOS. Endocrine 30: 19-26.
4. Hickey TE, Legro RS, Norman RJ, (2006) Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 91: 2789-2791.
5. van Houten E, Mcluskey A, Kramer P, Karels B, Themmen A, et al. (2011) Development of a mouse model with polycystic ovary syndrome. pp. P94.
6. Vanky E, Salvesen KÅ, Heimstad R, Fougner K, Romundstad P, et al. (2004) Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Human Reproduction 19: 1734-1740.
7. Goldenberg N, Glueck C, (2008) Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Minerva ginecologica 60: 63-75.
8. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, et al. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology & Metabolism 89: 2745-2749.
9. Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I, (2009) The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Human Reproduction 24: 2917-2923.
10. Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, et al. (2011) Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism 96: E48-E56.
11. Cupisti S, Giltay EJ, Gooren LJ, Kronawitter D, Oppelt PG, et al. (2010) The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome. Fertility and sterility 94: 2647-2653.
12. Halperin IJ, Kumar SS, Stroup DF, Laredo SE, (2011) The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. Human Reproduction 26: 191-201.
13. Cho L, Kilpatrick E, Keevil B, Coady A, Atkin S, (2009) Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome. Clinical endocrinology 70: 233-237.
14. Xu N, Kwon S, Abbott DH, Geller DH, Dumesic DA, et al. (2011) Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One 6: e27286.
15. Qu F, Wang FF, Yin R, Ding GL, El-Prince M, et al. (2012) A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl) 90: 911-923.
16. Li Z, Huang H, (2008) Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Med Hypotheses 70: 638-642.
17. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, et al. (2006) Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. Journal of Clinical Endocrinology & Metabolism 91: 4237-4245.
18. Ly LP, Handelsman DJ, (2005) Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 152: 471-478.
19. Angioni S, Sanna S, Magnini R, Melis GB, Fulghesu AM, (2011) The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome. Gynecol Endocrinol 27: 468-474.
20. Pomraning KR, Smith KM, Freitag M, (2009) Genome-wide high throughput analysis of DNA methylation in eukaryotes. Methods 47: 142-150.
21. Prasad TSK, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human protein reference database-2009 update. Nucleic acids research 37: D767-D772.
22. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R, et al. (2011) The BioGRID interaction database: 2011 update. Nucleic acids research 39: D698-D704.
23. Da Wei Huang BTS, Lempicki RA, (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4: 44-57.
24. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504.
25. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, et al. (2006) Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A 103: 17402-17407.
26. Baillargeon JP, Iuorno MJ, Nestler JE, (2003) Insulin sensitizers for polycystic ovary syndrome. Clinical obstetrics and gynecology 46: 325.
27. Tosi F, Dorizzi R, Castello R, Maffeis C, Spiazzi G, et al. (2009) Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome. European Journal of Endocrinology 161: 737-745.
28. Tasali E, Chapotot F, Leproult R, Whitmore H, Ehrmann DA, (2011) Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism 96: 365-374.
29. Kaboord B, Perr M, (2008) Isolation of proteins and protein complexes by immunoprecipitation. Methods Mol Biol 424: 349-364.
30. Irizarry RA, Ladd-Acosta C, Carvalho B, Wu H, Brandenburg SA, et al. (2008) Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 18: 780-790.
31. Swedenborg E, Power KA, Cai W, Pongratz I, Ruegg J, (2009) Regulation of estrogen receptor beta activity and implications in health and disease. Cell Mol Life Sci 66: 3873-3894.
32. Kim JJ, Choi YM, Choung SH, Yoon SH, Lee GH, et al. (2010) Estrogen receptor beta gene +1730 G/A polymorphism in women with polycystic ovary syndrome. Fertil Steril 93: 1942-1947.
33. Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, et al. (1992) Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79: 460-466.
34. Harries LW, Pilling LC, Hernandez LD, Bradley-Smith R, Henley W, et al. (2012) CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength. Aging Cell 11: 262-268.
35. Huang AM, Rudelius M, Sharan S, McAllister JM, Raffeld M, et al. (2007) The Cebpd (C/EBPdelta) gene is induced by luteinizing hormones in ovarian theca and interstitial cells but is not essential for mouse ovary function. PLoS One 2: e1334.
36. Yamamoto H, Kurebayashi S, Hirose T, Kouhara H, Kasayama S, (2002) Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts. J Cell Sci 115: 3601-3607.
37. Sandstrom LP, Sandstrom PA, Pennington SN, (1993) Ethanol-induced insulin resistance suppresses the expression of embryonic ornithine decarboxylase activity. Alcohol 10: 303-310.
38. Kumar H, Kawai T, Akira S, (2009) Pathogen recognition in the innate immune response. Biochem J 420: 1-16.
39. Kai A, Arashida T, Hatanaka K, Akaike T, Matsuzaki K, et al. (1994) Analysis of the biosynthetic process of cellulose and curdlan using 13C-labeled glucoses. Carbohydrate polymers 23: 235-239.
40. Schwartzman RA, CIDLOWSKI JA, (1993) Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine reviews 14: 133-151.
41. Bianco R, Melisi D, Ciardiello F, Tortora G, (2006) Key cancer cell signal transduction pathways as therapeutic targets. Eur J Cancer 42: 290-294.